Manganese Superoxide Dismutase Gene Polymorphism and Schizophrenia Relation to Tardive Dyskinesia

ECDEU Assessment Manual for Psychopharmacology

1976 • 8,729 citations

Monte Carlo tests for associations between disease and alleles at highly polymorphic loci

1995 • 923 citations

Tardive Dyskinesia

1982 • 660 citations

Structural Dimorphism in the Mitochondrial Targeting Sequence in the Human Manganese Superoxide Dismutase Gene

1996 • 494 citations

Fatty acid levels in the brains of schizophrenics and normal controls

1991 • 250 citations

Markers of Glutamatergic Neurotransmission and Oxidative Stress Associated With Tardive Dyskinesia

1998 • 247 citations

Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients

1997 • 242 citations

Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia

1991 • 193 citations

Iron and oxygen radicals in brain

1992 • 186 citations

Human Mitochondrial Manganese Superoxide Dismutase Polymorphic Variant Ile58Thr Reduces Activity by Destabilizing the Tetrameric Interface^,

1996 • 182 citations

Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia

1990 • 177 citations

Impaired antioxidant defense at the onset of psychosis

1996 • 160 citations

Enzymes of the antioxidant defense system in chronic schizophrenic patients

1991 • 159 citations

Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia

1999 • 153 citations

Absence of electron transport (Rho 0 state) restores growth of a manganese-superoxide dismutase-deficient Saccharomyces cerevisiae in hyperoxia. Evidence for electron transport as a major source of superoxide generation in vivo.

1993 • 151 citations

Treatment of tardive dyskinesia with vitamin E

1992 • 148 citations

Vitamin E treatment of tardive dyskinesia

1993 • 136 citations

EVIDENCE OF ENHANCED LIPID PEROXIDATION IN THE CEREBROSPINAL FLUID OF PATIENTS TAKING PHENOTHIAZINES

1987 • 105 citations

A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.

1996 • 104 citations

Benefits and pitfalls encountered in psychiatric genetic association studies

1999 • 97 citations

Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotype

1997 • 96 citations

Analysis of Mitochondrial Targeting Sequence and Coding Region Polymorphisms of the Manganese Superoxide Dismutase Gene in German Parkinson Disease Patients

1999 • 82 citations

Differential effects of acute and chronic administration of haloperidol on homovanillic acid levels in discrete dopaminergic areas of rat brain

1983 • 78 citations

Tardive dyskinesia and debrisoquine 4-hydroxylase (CYP2D6) genotype in Japanese schizophrenics

1998 • 77 citations

Identification of two novel mutations and a new polymorphism in the gene for Cu/Zn superoxide dismutase in patients with amyotrophic lateral sclerosis

1994 • 77 citations

Mn SOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson's disease and control

1997 • 74 citations

Effects of over- and under-expression of Cu,Zn-superoxide dismutase on the toxicity of glutamate analogs in transgenic mouse striatum

1998 • 52 citations

Duration of Neuroleptic Treatment and Prevalence of Tardive Dyskinesia in Late Life

1995 • 37 citations

BRIEF COMMUNICATION

1997 • 35 citations

Elevated levels of lipid peroxidation products in plasma of drug-naive patients at the onset of psychosis

1995 • 27 citations

Vitamin E treatment of tardive dyskinesia

1992 • 25 citations

Mitogenic response to basic fibroblast growth factor (BFGF) in cultured skin fibroblasts from first episode psychosis patients

1995 • 24 citations

Tardive Dyskinesia: A Review

1995 • 23 citations

Tardive Dyskinesia Prevalence Rates During a Ten-Year Follow-Up

1995 • 21 citations

Familial occurrence of tardive dyskinesia

1998 • 5 citations

Deleted Work

1955 • 0 citations